Benefit-risk assessment of acne therapies.

Lancet

Volumn 349, Issue 9060, 1997, Pages 1252-

  Beneton N ^a   Bocquet, H ^a   Cosnes, A ^a   Revuz, J ^a   Roujeau, J C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MINOCYCLINE;

ACNE VULGARIS; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; EOSINOPHILIA; HUMAN; NEGRO; NEWBORN EXFOLIATIVE DERMATITIS; NOTE; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; TOXIC HEPATITIS;

ACNE VULGARIS; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-BACTERIAL AGENTS; DERMATITIS, EXFOLIATIVE; DRUG ERUPTIONS; EOSINOPHILIA; HEPATITIS, TOXIC; HUMANS; MINOCYCLINE; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT;

EID: 0031586867     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62446-4     Document Type: Letter

References (0)